379 related articles for article (PubMed ID: 3043683)
21. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
Greene P; Cote L; Fahn S
Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
[No Abstract] [Full Text] [Related]
22. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease.
Ahlskog JE; Muenter MD; McManis PG; Bell GN; Bailey PA
Mayo Clin Proc; 1988 Sep; 63(9):876-86. PubMed ID: 3045435
[TBL] [Abstract][Full Text] [Related]
23. Clinical inquiry. Which drugs work best for early Parkinson's disease?
Jain L; Benko R; Safranek S
J Fam Pract; 2012 Feb; 61(2):106-8. PubMed ID: 22312616
[TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease.
Lieberman AN
Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
[No Abstract] [Full Text] [Related]
25. [Treatment possibilities in advanced Parkinson's disease].
Takáts A; Nagy H; Radics P; Tóth A; Tamás G
Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235
[TBL] [Abstract][Full Text] [Related]
26. Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
Rondot P; Ziegler M; Aymard N; Teinturier A
Neurology; 1989 Nov; 39(11 Suppl 2):74-7; discussion 95. PubMed ID: 2586765
[TBL] [Abstract][Full Text] [Related]
27. First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease.
Senek M; Hellström M; Albo J; Svenningsson P; Nyholm D
Acta Neurol Scand; 2017 Dec; 136(6):727-731. PubMed ID: 28299787
[TBL] [Abstract][Full Text] [Related]
28. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.
Langston JW; Ballard P
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):160-5. PubMed ID: 6608979
[TBL] [Abstract][Full Text] [Related]
29. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.
Catalán MJ; Escribano PM; Alonso-Frech F
Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835
[No Abstract] [Full Text] [Related]
30. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients.
Olanow CW; Nakano K; Nausieda P; Tetrud JA; Manyam B; Last B; Block G; Liss C; Bush D
Clin Neuropharmacol; 1991 Jun; 14(3):235-40. PubMed ID: 2070363
[TBL] [Abstract][Full Text] [Related]
31. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.
Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C
Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946
[No Abstract] [Full Text] [Related]
32. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
Ahlskog JE
Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
[TBL] [Abstract][Full Text] [Related]
33. Treatment of early Parkinson's disease with controlled-release levodopa preparations.
Rinne UK; Rinne JO
Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766
[TBL] [Abstract][Full Text] [Related]
34. Case report: successful use of rectally administered levodopa-carbidopa.
Cooper SD; Ismail HA; Frank C
Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
[No Abstract] [Full Text] [Related]
35. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
[TBL] [Abstract][Full Text] [Related]
36. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
37. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
[TBL] [Abstract][Full Text] [Related]
38. Square-wave action dystonia in Parkinson's disease.
van den Munckhof P; Lenz FA; Chase TN
Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
[No Abstract] [Full Text] [Related]
39. [Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].
Santos-Garcia D; de Deus T; Lopez-Pazos E; Macias-Arribi M; Llaneza-Gonzalez MA; Echarri-Piudo A; Carpintero P; de la Fuente-Fernandez R
Rev Neurol; 2014 Jun; 58(11):505-15. PubMed ID: 24861226
[TBL] [Abstract][Full Text] [Related]
40. Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and Wales.
Kalabina S; Belsey J; Pivonka D; Mohamed B; Thomas C; Paterson B
J Med Econ; 2019 Mar; 22(3):215-225. PubMed ID: 30484353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]